InsiderTrades

Form 4 for SNDX Syndax Pharmaceuticals Inc

Accepted 2022-04-05 00:00:00 ET · period of report 2022-04-01 · accession 0001562180-22-003223 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-04-05 2022-04-01+ SNDX Morrison Briggs Pres, Head of R, D, Dir S - Sale+OE $17.48 -104.2K 42.3K -71% -$1.82M
DM 2022-04-05 2022-04-01+ SNDX Morrison Briggs Pres, Head of R, D, Dir M - OptEx $10.90 +73.7K 88.4K +501% +$803.0K
DM 2022-04-05 2022-04-01+ SNDX Morrison Briggs Pres, Head of R, D, Dir M - OptEx $0.00 -73.7K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-04-04 S D 3,128 $18.29 17,836 D — — (F5) The sale prices ranged from $17.75 to $19.17.
2 Common Common Stock 2022-04-04 M A 3,128 $10.90 20,964 D — —
3 Common Common Stock 2022-04-01 S D 70,545 $17.46 17,836 D — — (F4) The sale prices ranged from $17.18 to $17.69.
4 Common Common Stock 2022-04-01 M A 70,545 $10.90 88,381 D — —
5 Common Common Stock 2022-04-01 S D 24,500 $17.44 17,836 D — — (F3) The sale prices ranged from $17.19 to $17.66.
6 Common Common Stock 2022-04-01 S D 6,000 $17.44 42,336 D — — (F2) The sale prices ranged from $17.21 to $17.62.
7 Derivative Stock Options (Right to buy) 2022-04-01 M D 70,545 $0.00 0 D $10.90 · — to 2025-09-09 70,545 Common Stock (F6) This option is fully vested.
8 Derivative Stock Options (Right to buy) 2022-04-04 M D 3,128 $0.00 0 D $10.90 · — to 2025-09-09 3,128 Common Stock (F6) This option is fully vested.